n.krastev
TL2 Moderator · Cork
Contributes reviews on supplier material. Based in Cork.
Joined 24 June 2025 · last posted 23h
67 posts, newest first. Showing up to 150.
-
Why a pen's dose steps are fixed and what that costs you Replied, post #5 · Devices › Pens & autoinjectors · 27 Jul 2026 · 0 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #45 · Start Here › Welcome · 15 Jul 2026 · 13 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
Second pass at: When your prescriber and the evidence disagree Replied, post #45 · Clinical › Prescriber conversations · 4 Jul 2026 · 8 likes Worth separating two things that post #41 runs together. Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #40 · Pharmacology › Pharmacokinetics · 3 Jul 2026 · 3 likes Coming back to post #38, because the follow-up matters more than the original answer. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days.…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #21 · Practice › Administration · 23 Jun 2026 · 6 likes Coming back to post #19, because the follow-up matters more than the original answer. Cold solution and stinging: warming the vial in your hands for a minute before…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #29 · Analytics › Method validation · 12 Jun 2026 · 0 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Reading a trial's population section before its results Replied, post #101 · Evidence › Trials · 8 Jun 2026 · 13 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #30 · Evidence › Journal club · 30 May 2026 · 15 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
The anatomy of a question that gets answered within an hour Replied, post #54 · Start Here › How to Ask · 23 May 2026 · 0 likes Worth separating two things that post #50 runs together. Lab result questions: state the result, the reference interval, and what else is on the same panel. A single…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #55 · Practice › Administration · 6 Apr 2026 · 5 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
The "under review" status pill and when a moderator applies it Replied, post #11 · Evidence › Preprints · 7 Mar 2026 · 12 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #58 · Clinical › Special populations · 1 Mar 2026 · 1 like Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Personal import allowances, compared — a second dataset Replied, post #76 · Access › International · 27 Feb 2026 · 20 likes Worth separating two things that post #72 runs together. Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #66 · Practice › Dosing & titration · 18 Feb 2026 · 13 likes post #65 answers the question as asked. The question underneath it is different. Stepping down deliberately: the withdrawal trials show that stopping is followed by…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #68 · Compounds › Semaglutide · 17 Feb 2026 · 28 likes post #67 answers the question as asked. The question underneath it is different. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
[2026 update] What a good consultation looks like from the other side Replied, post #16 · Clinical › Prescriber conversations · 14 Feb 2026 · 11 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
Trifluoroacetate content and its consequences Replied, post #101 · Analytics › Impurities & related substances · 7 Feb 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #44 · Practice › Interactions · 31 Jan 2026 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #88 · Clinical › Special populations · 25 Jan 2026 · 5 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #84 · Clinical › Special populations · 25 Jan 2026 · 0 likes This follows post #81 rather than contradicting it. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #63 · Clinical › Special populations · 24 Jan 2026 · 32 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #49 · Clinical › Bloodwork · 11 Jan 2026 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #34 · Devices › Pens & autoinjectors · 23 Dec 2025 · 6 likes post #33 answers the question as asked. The question underneath it is different. Reusability: some pens are single-use (throw away after one injection). Others can be…
-
Heterogeneity as information rather than as a nuisance Replied, post #23 · Evidence › Meta-analyses · 12 Dec 2025 · 5 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Cross-border purchase rules within the EU Replied, post #50 · Regional › European Union · 6 Dec 2025 · 8 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #22 · Practice › Side effects · 25 Nov 2025 · 0 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Lurking for two months before posting: was that the right call? Replied, post #70 · Start Here › Welcome · 21 Nov 2025 · 1 like On post #66 — agreed on the reasoning, with one qualification. On the reading order question specifically: start with the how-to-ask materials in this category, then…
-
Pen dose counters: what a click does and does not guarantee Replied, post #118 · Devices › Pens & autoinjectors · 20 Nov 2025 · 0 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
Second pass at: The mass-error checker and its intended scope Replied, post #43 · Data & Tools › Calculators · 20 Oct 2025 · 20 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #79 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 2 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Waist circumference technique and its repeatability Replied, post #3 · Outcomes › Progress reports · 28 Sep 2025 · 1 like Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #6 · Analytics › Home & field testing · 3 Sep 2025 · 12 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #56 · Evidence › Journal club · 29 Aug 2025 · 14 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #48 · Practice › Reconstitution · 27 Aug 2025 · 25 likes post #47 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #104 · Practice › Storage & stability · 4 Aug 2025 · 2 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #29 · Analytics › Mass spectrometry · 25 Jun 2025 · 4 likes post #28 answers the question as asked. The question underneath it is different. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+…
-
Repeatability versus intermediate precision Replied, post #23 · Analytics › Method validation · 20 Jun 2025 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Repeatability versus intermediate precision Replied, post #7 · Analytics › Method validation · 17 Jun 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #92 · Compounds › Tirzepatide · 24 May 2025 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #15 · Research Methods › N-of-1 designs · 18 May 2025 · 4 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
When to stop reading forums, including this one — the long version Replied, post #8 · Wellbeing › Mental health · 3 May 2025 · 18 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #65 · Practice › Reconstitution · 2 May 2025 · 6 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #6 · Wellbeing › Mental health · 9 Apr 2025 · 13 likes Worth separating two things that post #2 runs together. Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and…
-
Validating a method you did not develop — does this still hold? Replied, post #131 · Analytics › Method validation · 18 Mar 2025 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Retatrutide dose escalation in the published trials Replied, post #23 · Compounds › Retatrutide · 18 Mar 2025 · 22 likes post #22 is right about the mechanism and I think understates the practical bit. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #42 · Sourcing › Vendor reports · 16 Mar 2025 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #27 · Access › Pricing · 7 Mar 2025 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #82 · Compounds › Semaglutide · 1 Mar 2025 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Consistent declarations and why they matter more than clever ones Replied, post #75 · Sourcing › Logistics · 23 Feb 2025 · 6 likes post #74 answers the question as asked. The question underneath it is different. Import restrictions by jurisdiction: what is legal to import for personal use varies…
-
How compounding permissions changed when supply normalised Replied, post #22 · Sourcing › Regulatory · 22 Feb 2025 · 2 likes On post #18 — agreed on the reasoning, with one qualification. Regulatory positions change: a compound's status today might differ from its status a year from now.…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #50 · Practice › Side effects · 15 Feb 2025 · 0 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Canadian access and provincial variation Replied, post #59 · Regional › North America · 6 Feb 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 28 Jan 2025 · 1 like For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Follow-up: What is genuinely unknown about long-term amylin agonism Started this topic · Compounds › Cagrilintide & amylin analogues · 17 Jan 2025 · 0 likes What is genuinely unknown about long-term amylin agonism I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SUSTAIN 6…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #7 · Evidence › Meta-analyses · 17 Dec 2024 · 20 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Coming back to: When to suspect the method rather than the sample Replied, post #50 · Analytics › Method validation · 9 Dec 2024 · 27 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Turnaround times and what they mean for a decision — one year on Replied, post #20 · Sourcing › Independent verification · 9 Dec 2024 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Washout with a one-week half-life: the arithmetic Replied, post #96 · Research Methods › N-of-1 designs · 9 Dec 2024 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #52 · Evidence › Journal club · 6 Dec 2024 · 0 likes On post #48 — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #8 · Evidence › Trials · 29 Nov 2024 · 13 likes I read post #6 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #41 · Meta › Wiki maintenance · 19 Nov 2024 · 0 likes Picking up post #38: that is the part I would want checked first. Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #139 · Clinical › Bloodwork · 24 Oct 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #112 · Access › Shortages · 13 Oct 2024 · 0 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
When a red flag was a misunderstanding, and the retraction Replied, post #14 · Sourcing › Red flags · 9 Sep 2024 · 2 likes post #13 answers the question as asked. The question underneath it is different. Exaggerated claims without documentation: every compound has limits. No peptide is…
-
Circumference measurements as a poor man's composition estimate Replied, post #23 · Outcomes › Body composition · 27 Jul 2024 · 1 like post #22 answers the question as asked. The question underneath it is different. Comparison to published data: the trials reported mean fat and lean mass changes.…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #14 · Compounds › Retatrutide · 16 Jul 2024 · 32 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How this community labels and discusses unrefereed work Replied, post #47 · Evidence › Preprints · 28 Jun 2024 · 0 likes Picking up post #44: that is the part I would want checked first. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…